Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Fatty Liver × Other × Clear all

Phase

Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 4 Mucositis 4 Stomatitis 3 Dyspnea 3 Polycystic Ovary Syndrome 2 Head and Neck Neoplasms 2 Pain 1 Overweight 1 Oropharyngeal Neoplasms 1 Oral Ulcer 1 Opioid-Induced Constipation 1 Neoplasms 1 Motor Activity 1 Lymphoma, Follicular 1 Infertility 1 Hypoxia 1 Fatty Liver 1 Endometrial Neoplasms 1 Constipation 1 Breast Neoplasms 1 Acidosis, Respiratory 1

Interventions

penclomedine 1 Exenatide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡